Jayesh Vora

<i>In vivo</i> Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models

Sang Hoon Lee, Daniel L. Menezes, Jayesh Vora et al. · Clinical Cancer Research · 2005 · 173 citations

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 134 citations · Full text

Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases

Christopher M. McBride, Paul A. Renhowe, Carla Heise et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 45 citations · Full text

Structure–activity Relationship, Molecular Pharmacology, Medicinal Chemistry +13

Protective Effect of Butylated Hydroxyanisole on Adriamycin-induced Cardiotoxicity

Jayesh Vora, Ban‐An Khaw, Jagat Narula et al. · Journal of Pharmacy and Pharmacology · 1996 · 29 citations · Full text

Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases

Kelly Frazier, Elisa M. Jazan, Christopher M. McBride et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 12 citations · Full text

Structure–activity Relationship, Medicinal Chemistry, Biochemistry +9